Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905.

J Antibiot (Tokyo)

Graduate School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, Japan.

Published: April 2010

AI Article Synopsis

  • Calpinactam is a new anti-mycobacterial agent discovered from the fungal strain Mortierella alpina FKI-4905 through laboratory techniques like solvent extraction and chromatography.
  • It specifically targets Mycobacteria, showing no activity against other microbes, including Gram-positive and Gram-negative bacteria, fungi, or yeasts.
  • The compound effectively inhibited Mycobacterium smegmatis and Mycobacterium tuberculosis, with minimum inhibitory concentrations (MICs) of 0.78 and 12.5 microg/ml, respectively.

Article Abstract

Calpinactam, a new anti-mycobacterial agent, was isolated from the culture broth of a fungal strain Mortierella alpina FKI-4905 by solvent extraction, octadecyl silane column chromatography and preparative HPLC. Calpinactam was active only against Mycobacteria among various microorganisms, including Gram-positive and Gram-negative bacteria, fungi and yeasts. Calpinactam inhibited the growth of Mycobacterium smegmatis and Mycobacterium tuberculosis with MIC values of 0.78 and 12.5 microg ml(-1), respectively.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ja.2010.14DOI Listing

Publication Analysis

Top Keywords

calpinactam anti-mycobacterial
8
anti-mycobacterial agent
8
mortierella alpina
8
alpina fki-4905
8
calpinactam
4
agent produced
4
produced mortierella
4
fki-4905 calpinactam
4
agent isolated
4
isolated culture
4

Similar Publications

Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905.

J Antibiot (Tokyo)

April 2010

Graduate School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, Japan.

Article Synopsis
  • Calpinactam is a new anti-mycobacterial agent discovered from the fungal strain Mortierella alpina FKI-4905 through laboratory techniques like solvent extraction and chromatography.
  • It specifically targets Mycobacteria, showing no activity against other microbes, including Gram-positive and Gram-negative bacteria, fungi, or yeasts.
  • The compound effectively inhibited Mycobacterium smegmatis and Mycobacterium tuberculosis, with minimum inhibitory concentrations (MICs) of 0.78 and 12.5 microg/ml, respectively.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!